Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.

Saved in:
Bibliographic Details
Title: Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma.
Authors: Goldshmit Y; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. Australian Regenerative Medicine Institute, Monash University, Australia. These authors contributed equally to this work., Trangle SS; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel. These authors contributed equally to this work., Kloog Y; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel., Pinkas-Kramarski R; Department of Neurobiology, Tel-Aviv University, Ramat-Aviv, Israel.
Source: Oncotarget [Oncotarget] 2014 Sep 30; Vol. 5 (18), pp. 8602-13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.2343